COLUMBIA SPORTSWEAR CO (COLM): what the price requires

At today's price, COLUMBIA SPORTSWEAR CO (COLM) is priced for -3.1% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/COLM

Headline

FieldValue
TickerCOLM
CompanyCOLUMBIA SPORTSWEAR CO
Current price$63.98/sh
CompositionApparel, accessories and equipment 80% / Footwear 20%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed3.8%
Operating margin (mid-cycle)10.7%
Margin compression implied-6.9pp
Trailing margin (depressed year)4.3%
Implied growth-3.1%
Multiple paid10x mid-cycle operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 9.4% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~5pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.47σ
cohort percentile (of 210 peers)16
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.72x5expensive
Earnings2.26x4expensive
Relative0.99x3justifies
Growth1.27x3expensive

Families that justify the price: Relative Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.

Per-Model Detail (n=15)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$43.531.47xyesFCF base $0.2B, growth 1% (input: historical growth), terminal g 1.3%, WACC 8.0%, 5yr projection
DCF Exit MultipleGrowth$67.120.95xyesExit EV/EBITDA: 13.3x / 15.3x / 17.3x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$64.460.99xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.5x / 22.0x / 25.5x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$34.721.84xyesBV/sh $30.02, ROE (TTM) 10.7%, ke 9.3%
Two-Stage Excess ReturnAsset$37.251.72xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$50.301.27xyesRev $3.4B, growth 1% (input: historical growth; tapered), Terminal P/S: 0.8x / 1.0x / 1.1x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$50.701.26xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.32B × (1−27%) / WACC 8.0% → EPV (no growth)
Residual IncomeAsset$37.731.70xyesBV $30.02 + 5yr PV of (ROE (TTM) 10.7% − Kₑ 9.3%) × BV; BV grows 7.0%/yr
Graham NumberAsset$46.051.39xyes√(22.5 × EPS $3.14 × BVPS $30.02) — Graham's conservative floor
EV/EBITDA RelativeRelative$57.421.11xyesEBITDA $0.26B × sector EV/EBITDA 14.0x
FCF YieldEarnings$24.232.64xyesFCF $174.4M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$18.993.37xyesSBC-adj FCF $0.15B (FCF $0.17B − SBC $0.03B) capitalized at Kₑ
Ben Graham FormulaEarnings$2.6324.33xyesEPS $3.14 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$5.2012.30xyesBV $30.02 × (ROIC 1.4% / WACC 8.0%)
P/Sales SectorRelative$128.950.50xyesRevenue $3.40B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$33.951.88xyesEPS $3.14 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$535.4m
Net debt / NOPAT (after-tax)-2.21x (net cash)
Net debt / operating income (pre-tax)-1.61x (net cash)
Share count CAGR (buyback)-5.0%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 10.7%); the trailing year was depressed.

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Columbia Sportswear runs a roughly 50% gross margin and a fortress balance sheet, about $535 million of cash and zero debt, on its outdoor apparel and footwear brands. The brand and the cash are the durable parts; the operating margin, near 6%, is the part under pressure.

The near-term picture is mixed but improving. First-quarter 2026 EPS of $0.65 beat sharply, the company raised full-year EPS guidance to $3.55 to $4.00, and international sales grew 16% while U.S. sales fell 10% on tariff-driven order caution. The risks are demand cyclicality, wholesale dependence, and tariffs costing about 200 basis points of margin.

Bull Case

Start from the competitive moat, because the margin and balance-sheet data show it is real even in a soft year. Columbia Sportswear carries a gross margin around 50.7%, a level that only a genuine brand commands; a commodity apparel maker would earn half that. That margin reflects pricing power across a portfolio of recognized outdoor brands, Columbia, SOREL, Mountain Hardwear, and prAna, sold through both wholesale and a growing direct-to-consumer channel. The company competes in highly competitive markets against global and regional branded apparel, footwear, and equipment companies (FY2025 10-K, accession 0001050797-26-000028), and it defends its position with marketing across digital, television, and in-store visual merchandising (accession 0001050797-26-000028). A ~50% gross margin sustained against that competition is the clearest evidence the brand is the moat, not a marketing line.

The balance sheet turns that brand into optionality. Columbia holds about $535 million of cash and carries no debt at all, an unusually pristine position for a consumer-cyclical company. That fortress does three things: it funds a steady buyback (the company repurchased $150 million of stock in the quarter and has shrunk the share count about 5% a year), it pays a growing dividend ($0.30 quarterly), and it lets management invest through a downturn rather than retrench. A debt-free brand with high gross margins can weather a weak demand year, keep buying back stock at depressed prices, and emerge with fewer shares and the same brand, which is exactly how a quality consumer name compounds through a cycle.

The recent execution shows the trough may be passing. First-quarter 2026 EPS of $0.65 beat the $0.34 consensus handily, on revenue of $779 million that came in ahead of expectations, driven by early Spring wholesale shipments and better-than-expected demand in Europe and the U.S. International sales grew 16%, offsetting an anticipated 10% U.S. decline that stemmed largely from a deliberate, precautionary cut to winter product supply ahead of tariff announcements. Crucially, management raised full-year 2026 EPS guidance to $3.55 to $4.00 from $3.20 to $3.65 on improved tariff dynamics, a rare upward revision in a cautious retail environment. For a buyer, the package is a real brand at a high gross margin, a debt-free balance sheet shrinking the share count, and a guidance raise signaling the operating margin can recover from here.

Bear Case

The structural observation that matters here is the inverse of the usual one: the balance sheet is not fragile, it is almost too strong, and the fragility lives in the operating model the cash cannot fix. Columbia has about $535 million of net cash and no debt, so there is no leverage risk and no liquidity risk. But that also means the company has no financial lever to manufacture growth, and the cash sitting on the balance sheet earns a low return while the operating margin erodes. Operating income fell 10% to $42 million in the first quarter and the operating margin sits near 6%, down from the low double digits the company earned in better years. A fortress balance sheet does nothing to cushion a structurally compressing operating margin; it just means the decline shows up in returns on a pile of idle cash rather than in solvency. The asset and earnings-power methods, which value the business on its current returns, land in the mid-$30s to low $50s, well below the $66.50 price (June 27, 2026), because a 6% operating margin and a 10.7% return on equity that barely clears the cost of capital do not support a premium.

The demand side is genuinely cyclical and partly outside the company's control. Columbia plans and sources product well in advance of the selling season and is subject to numerous risks affecting consumer and customer demand (FY2025 10-K, accession 0001050797-26-000028), which for an outdoor brand includes weather: a warm winter leaves cold-weather inventory unsold and forces markdowns that hit the very gross margin the bull case celebrates. The U.S. business, its largest market, declined 10%, and while management attributes part of that to a deliberate winter-supply cut, a lower spring order book also signals softer underlying wholesale demand. The company has no long-term contracts with its wholesale customers (accession 0001050797-26-000028), so orders can be cut or canceled, and it warns that economic weakness can hurt its DTC brick-and-mortar operations and the financial health of wholesale customers, some of whom may reduce store fleets, restructure, or file for bankruptcy (accession 0001050797-26-000028). That is real channel risk concentrated in a discretionary category.

Tariffs are the live margin threat. Full-year 2026 gross margin guidance of 50.3% to 50.5% already bakes in roughly 200 basis points of tariff impact, a direct hit to the moat metric, and the company cut winter supply specifically as a precaution against tariff announcements, sacrificing some sales to manage the risk. Rising SG&A is the other squeeze: EMEA segment SG&A rose to 25.4% of net sales from 24.6% on higher direct-to-consumer brick-and-mortar costs from new stores (FY2025 10-K, accession 0001050797-26-000028), so even as the company grows DTC, the cost of doing so eats the margin benefit. A buyer at $66.50 is paying about 2.2x book and above the asset and earnings methods for a brand whose operating margin is compressed, whose largest market is shrinking, and whose gross margin faces a 200-basis-point tariff drag. The balance sheet protects the company from failure; it does not make the operating recovery automatic, and the price assumes that recovery.

Valuation

The methods land in a wide but readable range. The growth-DCF on the depressed current free cash flow lands near $43, the asset-based reads (excess return, residual income) near $35 to $38 on a 10.7% return on equity that barely clears the cost of equity, and the earnings-power read near $50. The methods that reach the price are the ones that assume normalization: the exit-multiple DCF near $69, the relative-valuation read at a sector P/E near 22x at $64, and the EV/EBITDA-relative read near $57. So at $66.50 the stock trades roughly in line with the relative and exit-multiple reads and above the asset and current-cash-flow reads, which is the typical configuration for a quality brand in a margin trough: cheap on normalized earnings, full on current ones.

Reading the price as an assumption sharpens it. The inversion shows the market pricing in roughly flat-to-slightly-negative operating-profit growth (about negative 1%) at a modest multiple, and the reverse band runs from about $79 at the low end to $86 at the base and $133 at the high end, with the current price sitting below the entire band. In plain terms, the market is pricing Columbia as if its operating margin stays compressed indefinitely. The raised 2026 EPS guidance of $3.55 to $4.00 argues against that: at the midpoint the stock trades near 17x to 18x earnings, a reasonable multiple for a debt-free brand, and the net cash of about $535 million means the operating business is being bought at an even lower effective multiple on an enterprise-value basis. The fair read is that the stock is reasonable to modestly undervalued if the operating margin recovers toward its historical range, and fairly valued if 6% margins are the new normal. The fortress balance sheet and the steady buyback provide downside support and a shrinking share count; the upside is the margin normalizing, which tariffs and a soft U.S. market are currently working against.

Catalysts

First-quarter 2026 was the recent set-piece and it beat sharply: EPS of $0.65 against a $0.34 consensus, on revenue of $779 million (essentially flat year over year but ahead of the $756 million expected). Gross margin contracted 20 basis points to 50.7% and operating income fell 10% to $42 million, so the beat came on the top line and tariff dynamics more than on margin. International sales grew 16% while U.S. sales fell 10%, the latter largely from a lower spring order book and a deliberate cut to winter product supply ahead of tariff announcements. (Sources: Columbia Sportswear Q1 2026 results via StockTitan and the company 8-K; Q1 2026 earnings transcript via The Motley Fool and Investing.com.)

The headline catalyst was the guidance raise: full-year 2026 diluted EPS guidance lifted to $3.55 to $4.00 from $3.20 to $3.65, with net sales guidance of $3.43 to $3.50 billion (1% to 3% growth) and gross margin of 50.3% to 50.5%, including roughly 200 basis points of tariff impact. The raise was attributed to improved tariff dynamics. The company repurchased $150 million of stock and declared a $0.30 quarterly dividend. (Sources: Columbia Sportswear 2026 guidance via StockTitan and The Globe and Mail; Q1 2026 recap via MarketBeat and Yahoo Finance.)

The forward watch items are demand- and tariff-driven: whether the U.S. wholesale order book stabilizes and international momentum continues, the trajectory of gross margin against the 200-basis-point tariff drag, SG&A discipline as direct-to-consumer expansion adds brick-and-mortar cost, and weather, which swings cold-weather product sell-through. The continued buyback and dividend provide return while the operating margin recovers. Each quarterly print and any tariff-policy development are the key catalysts. (Sources: Columbia Sportswear Q1 2026 guidance and commentary via Investing.com; Columbia Sportswear FY2025 10-K demand, wholesale, and SG&A disclosures.)

Peer Cohorts (Per Segment, With Filing Citations)

LAAP (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive COLM report on boothcheck